{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:30:19Z","timestamp":1793205019218,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473179"],"award-info":[{"award-number":["81473179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003708"],"award-info":[{"award-number":["82003708"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673388"],"award-info":[{"award-number":["81673388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204331"],"award-info":[{"award-number":["82204331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jpba.2024.116625","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T11:50:07Z","timestamp":1733485807000},"page":"116625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["State-of-the-art chromatographic and mass spectrometric techniques in heparin structural analysis"],"prefix":"10.1016","volume":"255","author":[{"given":"Yilan","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhou","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116625_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/b819896a","article-title":"Lessons learned from the contamination of heparin","volume":"26","author":"Liu","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jpba.2024.116625_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0037-1613209","article-title":"Platelet activation and blood coagulation","volume":"88","author":"Heemskerk","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jpba.2024.116625_bib3","series-title":"Heparin and Heparan Sulfate: Analyzing Structure and Microheterogeneity BT - Heparin - A Century of Progress","first-page":"159","author":"Shriver","year":"2012"},{"key":"10.1016\/j.jpba.2024.116625_bib4","series-title":"Heparin - A century of progress","author":"Alban","year":"2012"},{"key":"10.1016\/j.jpba.2024.116625_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B","article-title":"Heparin - protein interactions","volume":"41","author":"Capila","year":"2002","journal-title":"Angew. Chem. - Int. Ed."},{"key":"10.1016\/j.jpba.2024.116625_bib6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/elps.201500552","article-title":"Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: present trends and future opportunities","volume":"37","author":"Chandler","year":"2016","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2024.116625_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/ar030138x","article-title":"Role of glycosaminoglycans in cellular communication","volume":"37","author":"Linhardt","year":"2004","journal-title":"Acc. Chem. Res"},{"key":"10.1016\/j.jpba.2024.116625_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3389\/fphar.2020.01307","article-title":"The potential role of heparin in patients with COVID-19: beyond the anticoagulant effect. A review","volume":"11","author":"Gozzo","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.jpba.2024.116625_bib9","doi-asserted-by":"crossref","first-page":"L211","DOI":"10.1152\/ajplung.00199.2020","article-title":"Heparin as a therapy for COVID-19: current evidence and future possibilities","volume":"319","author":"Hippensteel","year":"2020","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.jpba.2024.116625_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/jth.14821","article-title":"The versatile heparin in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jpba.2024.116625_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph9030038","article-title":"Heparin: past, present, and future","volume":"9","author":"Oduah","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2024.116625_bib12","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1073\/pnas.77.11.6551","article-title":"Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin","volume":"77","author":"Lindahl","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpba.2024.116625_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ab.2014.02.033","article-title":"Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry","volume":"455","author":"Li","year":"2014","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.jpba.2024.116625_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpba.2018.10.052","article-title":"Chemometric analysis of porcine, bovine and ovine heparins","volume":"164","author":"Ouyang","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116625_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpba.2017.10.020","article-title":"Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools","volume":"149","author":"Monakhova","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116625_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/1076029616686422","article-title":"Comparison of low-molecular-weight heparins prepared from bovine heparins with enoxaparin","volume":"23","author":"Liu","year":"2017","journal-title":"Clin. Appl. Thromb. \/Hemost."},{"key":"10.1016\/j.jpba.2024.116625_bib17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.drudis.2014.07.004","article-title":"Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs","volume":"19","author":"Santos","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpba.2024.116625_bib18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1160\/TH11-07-0518","article-title":"Heparin from bovine intestinal mucosa: Glycans with multiple sulfation patterns and anticoagulant effects","volume":"107","author":"Tovar","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jpba.2024.116625_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/ajplegacy.1916.41.2.250","article-title":"The thromboplastic action of cephalin","volume":"41","author":"McLean","year":"1916","journal-title":"J. Am. J. Physiol."},{"key":"10.1016\/j.jpba.2024.116625_bib20","first-page":"283","article-title":"Bovine Spongiform Encephalopathy (BSE)","author":"Bradley","year":"2014","journal-title":"Encyclo Neurol. Sci."},{"key":"10.1016\/j.jpba.2024.116625_bib21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2024.116625_bib22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.xphs.2018.01.008","article-title":"Antithrombin III-binding site analysis of low-molecular-weight heparin fractions","volume":"107","author":"Chen","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2024.116625_bib23","first-page":"347","article-title":"Measurement of the Antithrombin III binding sites in low molecular weight heparins by 13C NMR and capillary electrophoresis","volume":"1","author":"Desai","year":"1995","journal-title":"Pharm. Pharm. Commun."},{"key":"10.1016\/j.jpba.2024.116625_bib24","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1073\/pnas.76.7.3198","article-title":"Structure of the antithrombin-binding site in heparin","volume":"76","author":"Lindahl","year":"1979","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jpba.2024.116625_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5811\/westjem.2014.12.22933","article-title":"Anticoagulation drug therapy: a review","volume":"16","author":"Harter","year":"2015","journal-title":"West J. Emerg. Med"},{"key":"10.1016\/j.jpba.2024.116625_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-9084(03)00078-6","article-title":"1976-1983, a critical period in the history of heparin: The discovery of the antithrombin binding site","volume":"85","author":"Petitou","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.jpba.2024.116625_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00216-010-4314-3","article-title":"Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs","volume":"399","author":"Castro-L\u00f3pez","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.carbpol.2014.01.100","article-title":"A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety\u2014a review","volume":"106","author":"Ingle","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jpba.2024.116625_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jpba.2024.116625_bib30","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jpba.2024.116625_bib31","first-page":"57","article-title":"Human pharmacokinetics of low molecular weight heparins","volume":"3","author":"Cornelli","year":"1999","journal-title":"Semin Thromb. Hemost."},{"key":"10.1016\/j.jpba.2024.116625_bib32","first-page":"95","article-title":"Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange","volume":"35","author":"Merli","year":"2010","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.jpba.2024.116625_bib33","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1378\/chest.115.5.1418","article-title":"S.Z. Goldhabcr, Clinical uses of low-molecular-weight heparins","volume":"115","author":"Aguilar","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.jpba.2024.116625_bib34","first-page":"5","article-title":"Production and chemical processing of low molecular weight heparins","volume":"3","author":"Linhardt","year":"1999","journal-title":"Semin Thromb. Hemost."},{"key":"10.1016\/j.jpba.2024.116625_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carbpol.2018.05.070","article-title":"Preparation LMWH from bovine and ovine heparin using nitrous acid","volume":"197","author":"Xie","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jpba.2024.116625_bib36","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1016\/0008-6215(84)85236-2","article-title":"Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III","volume":"132","author":"Sina\u00ff","year":"1984","journal-title":"Carbohydr. Res"},{"key":"10.1016\/j.jpba.2024.116625_bib37","first-page":"43","article-title":"Fondaparinux (Arixtra), a new anticoagulant","volume":"44","author":"Giangrande","year":"2002","journal-title":"Med Lett. Drugs Ther."},{"key":"10.1016\/j.jpba.2024.116625_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jpba.2024.116625_bib39","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1021\/jm800785t","article-title":"Oversulfated chondroitin sulfate: Impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation","volume":"51","author":"Zhang","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib40","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Kishimoto","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2024.116625_bib41","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1002\/jps.21729","article-title":"Analysis of pharmaceutical heparins and potential contaminants using1H NMR and PAGE","author":"Zhang","year":"2009","journal-title":"J. Pharm. Sci. 89"},{"key":"10.1016\/j.jpba.2024.116625_bib42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jpba.2008.12.013","article-title":"Analysis of heparin sodium by SAX\/HPLC for contaminants and impurities","volume":"49","author":"Trehy","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116625_bib43","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1021\/ac300176z","article-title":"Complete monosaccharide analysis by high-performance anion-exchange chromatography with pulsed amperometric detection","volume":"84","author":"Zhang","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib44","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1021\/ac200011s","article-title":"Sensitive detection of oversulfated chondroitin sulfate in heparin sodium or crude heparin with a colorimetric microplate based assay","volume":"83","author":"Sommers","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-1-0716-1398-6_24","article-title":"Glycosaminoglycan quality control by monosaccharide analysis","volume":"2303","author":"Zhang","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2024.116625_bib46","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/jssc.202001140","article-title":"Analysis of monosaccharide composition of water-soluble polysaccharides from Codium fragile by ultra-performance liquid chromatography-tandem mass spectrometry","volume":"44","author":"Li","year":"2021","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2024.116625_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2021.108400","article-title":"Optimizing acid hydrolysis for monosaccharide compositional analysis of Nostoc cf. linckia acidic exopolysaccharide","volume":"508","author":"Uhliarikov\u00e1","year":"2021","journal-title":"Carbohydr. Res"},{"key":"10.1016\/j.jpba.2024.116625_bib48","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jssc.201501205","article-title":"Monosaccharide composition analysis of immunomodulatory polysaccharides by on-line hollow fiber microextraction with high-performance liquid chromatography","volume":"39","author":"Wang","year":"2016","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2024.116625_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122629","article-title":"A comparative study of two HPLC methods for dissolved monosaccharide analysis in seawater using 2-amino benzamide and 2-amino pyrazine as pre-column derivatization reagents","volume":"234","author":"Alyuruk","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.116625_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1039\/C7AN01530E","article-title":"Revisiting monosaccharide analysis-quantitation of a comprehensive set of monosaccharides using dynamic multiple reaction monitoring","volume":"143","author":"Xu","year":"2018","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2024.116625_bib51","series-title":"USP 40 official monographs: Enoxaparin Sodium. In: United States pharmacopeia and national formulary (USP 40","author":"United States Pharmacopeial Convention","year":"2016"},{"key":"10.1016\/j.jpba.2024.116625_bib52","doi-asserted-by":"crossref","DOI":"10.1021\/ac60092a032","article-title":"Hydrolysis of polysaccharides by a cation exchange resin and identification of monosaccharide components by paper chromatography","volume":"26","author":"Glegg","year":"1954","journal-title":"Anal. Chem."},{"issue":"11-12","key":"10.1016\/j.jpba.2024.116625_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/10826070902956402","article-title":"Thin layer chromatography for the separation and analysis of acidic carbohydrates","volume":"32","author":"Zhang","year":"2009","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2024.116625_bib54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.chroma.2018.07.058","article-title":"Qualitative and quantitative analysis of 2, 5-anhydro-D-mannitol in low molecular weight heparins with high performance anion exchange chromatography hyphenated quadrupole time of flight mass spectrometry","volume":"1569","author":"Yi","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib55","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1021\/acs.analchem.1c04924","article-title":"Paired derivatization approach with H\/D-labeled hydroxylamine reagents for sensitive and accurate analysis of monosaccharides by liquid chromatography tandem mass spectrometry","volume":"94","author":"Wang","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib56","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1039\/C9AN00399A","article-title":"Systematic analysis of enoxaparins from different sources with online one- and two-dimensional chromatography","volume":"144","author":"Ouyang","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2024.116625_bib57","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acs.analchem.6b01709","article-title":"Comprehensive identification and quantitation of basic building blocks for low-molecular weight heparin","volume":"88","author":"Sun","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib58","first-page":"136","volume":"3","author":"United States Pharmacopeial Convention","year":"2016"},{"key":"10.1016\/j.jpba.2024.116625_bib59","series-title":"European pharmacopoeia","article-title":"Enoxaparin Sodium","author":"European Directorate for the Quality of Medicines and HealthCare","year":"2013"},{"key":"10.1016\/j.jpba.2024.116625_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ancr.2014.12.001","article-title":"Quantitative compositional analysis of heparin using exhaustive heparinase digestion and strong anion exchange chromatography","volume":"3","author":"Mourier","year":"2015","journal-title":"Anal. Chem. Res"},{"key":"10.1016\/j.jpba.2024.116625_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462049","article-title":"Comprehensive analysis of heparinase derived heparin-products using two-dimensional liquid chromatography coupled with mass spectrometry","volume":"1643","author":"Chen","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib62","doi-asserted-by":"crossref","first-page":"11542","DOI":"10.1021\/acs.analchem.6b02801","article-title":"Heparin isomeric oligosaccharide separation using volatile salt strong anion exchange chromatography","volume":"88","author":"Miller","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fmed.2019.00078","article-title":"SAX-HPLC and HSQC NMR spectroscopy: orthogonal methods for characterizing heparin batches composition","volume":"6","author":"Spelta","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jpba.2024.116625_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114616","article-title":"Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS","volume":"212","author":"Chen","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116625_bib65","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1021\/ac9001707","article-title":"Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry","volume":"81","author":"Zhang","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib66","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1021\/ac802770r","article-title":"Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography\/mass spectrometry","volume":"81","author":"Doneanu","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ab.2011.04.003","article-title":"Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis","volume":"415","author":"Yang","year":"2011","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.jpba.2024.116625_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.chroma.2013.02.013","article-title":"Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, Heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides","volume":"1284","author":"Galeotti","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.carres.2015.01.016","article-title":"Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry","volume":"407","author":"Xu","year":"2015","journal-title":"Carbohydr. Res"},{"key":"10.1016\/j.jpba.2024.116625_bib70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.chroma.2016.11.061","article-title":"Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization","volume":"1479","author":"Sun","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib71","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/ac3030448","article-title":"Disaccharide analysis of glycosaminoglycans using hydrophilic interaction chromatography and mass spectrometry","volume":"85","author":"Gill","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chroma.2016.03.078","article-title":"Oligosaccharide mapping of heparinase I-treated heparins by hydrophilic interaction liquid chromatography separation and online fluorescence detection and electrospray ionization-mass spectrometry characterization","volume":"1445","author":"Galeotti","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib73","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1021\/ac303185w","article-title":"Structural analysis of low molecular weight heparin by ultraperformance size exclusion chromatography\/time of flight mass spectrometry and capillary zone electrophoresis","volume":"85","author":"Zhang","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jchromb.2017.08.047","article-title":"Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis","volume":"1068\u20131069","author":"Zhang","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.116625_bib75","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/acs.analchem.5b04405","article-title":"Capillary electrophoresis-mass spectrometry for the analysis of heparin oligosaccharides and low molecular weight heparin","volume":"88","author":"Sun","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib76","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1021\/acs.analchem.8b03500","article-title":"Negative-ion mode capillary isoelectric focusing mass spectrometry for charge-based separation of acidic oligosaccharides","volume":"91","author":"Ouyang","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib77","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1021\/ac402242v","article-title":"Ultrasensitive detection and quantification of acidic disaccharides using capillary electrophoresis and quantum dot-based fluorescence resonance energy transfer","volume":"85","author":"Chang","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib78","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1021\/ac201426e","volume":"83","author":"Galeotti","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib79","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1021\/ac2021079","article-title":"Simultaneous analysis of Heparan sulfate, chondroitin\/dermatan sulfates, and hyaluronan disaccharides by glycoblotting-assisted sample preparation followed by single-step zwitter-ionic-hydrophilic interaction chromatography","volume":"83","author":"Takegawa","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ab.2012.05.004","article-title":"Analysis of glycosaminoglycan-derived disaccharides by capillary electrophoresis using laser-induced fluorescence detection","volume":"427","author":"Chang","year":"2012","journal-title":"Anal. Biochem"},{"key":"10.1016\/j.jpba.2024.116625_bib81","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1007\/s00216-014-7859-8","article-title":"Capillary electrophoresis for total glycosaminoglycan analysis","volume":"406","author":"Ucakturk","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib82","doi-asserted-by":"crossref","first-page":"11191","DOI":"10.1021\/acs.analchem.1c01761","article-title":"Improving the sensitivity for quantifying heparan sulfate from biological samples","volume":"93","author":"Wang","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib83","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1021\/ac302232c","article-title":"Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS","volume":"84","author":"Li","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib84","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.carres.2005.11.030","article-title":"Ion-pairing reversed-phased chromatography\/mass spectrometry of heparin","volume":"341","author":"Henriksen","year":"2006","journal-title":"Carbohydr. Res"},{"key":"10.1016\/j.jpba.2024.116625_bib85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0021-9673(03)01288-3","article-title":"Capillary electrophoretic separation of heparin oligosaccharides under conditions amenable to mass spectrometric detection","volume":"1014","author":"Gunay","year":"2003","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib86","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1021\/ac501301v","article-title":"Bottom-up low molecular weight heparin analysis using liquid chromatography-fourier transform mass spectrometry for extensive characterization","volume":"86","author":"Li","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.chroma.2015.04.054","article-title":"A rapid and accurate method for the quantitative estimation of natural polysaccharides and their fractions using high performance size exclusion chromatography coupled with multi-angle laser light scattering and refractive index detector","volume":"1400","author":"Cheong","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib88","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.3390\/molecules20035085","article-title":"Determination of the molecular weight of low-molecular-weight heparins by using high-pressure size exclusion chromatography on line with a triple detector array and conventional methods","volume":"20","author":"Bisio","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2024.116625_bib89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.chroma.2017.09.040","article-title":"Qualitative and quantitative analysis of heparin and low molecular weight heparins using size exclusion chromatography with multiple angle laser scattering\/refractive index and inductively coupled plasma\/mass spectrometry detectors","volume":"1522","author":"Ouyang","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib90","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1021\/acs.analchem.6b03081","article-title":"Complete molecular weight profiling of low-molecular weight heparins using size exclusion chromatography-ion suppressor-high-resolution mass spectrometry","volume":"88","author":"Zaia","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib91","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00216-016-9662-1","article-title":"Analysis of heparin oligosaccharides by capillary electrophoresis\u2013negative-ion electrospray ionization mass spectrometry","volume":"409","author":"Lin","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijms.2019.116209","article-title":"Online capillary zone electrophoresis negative electron transfer dissociation tandem mass spectrometry of glycosaminoglycan mixtures","volume":"445","author":"Stickney","year":"2019","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2024.116625_bib93","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s13361-017-1709-9","article-title":"Negative electron transfer dissociation sequencing of increasingly sulfated glycosaminoglycan oligosaccharides on an orbitrap mass spectrometer","volume":"28","author":"Leach","year":"2017","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jpba.2024.116625_bib94","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1007\/s13361-018-1907-0","article-title":"Negative electron transfer dissociation sequencing of 3-O-sulfation-containing heparan sulfate oligosaccharides","volume":"29","author":"Wu","year":"2018","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jpba.2024.116625_bib95","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1255\/ejms.1120","article-title":"Negative electron transfer dissociation Fourier transform mass spectrometry of glycosaminoglycan carbohydrates","volume":"17","author":"Leach","year":"2011","journal-title":"Eur. J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2024.116625_bib96","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1021\/ac100554a","article-title":"Negative electron transfer dissociation of glycosaminoglycans","volume":"82","author":"Wolff","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib97","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1021\/acs.analchem.5b02218","article-title":"Profiling analysis of low molecular weight heparins by multiple heart-cutting two dimensional chromatography with quadruple time-of-flight mass spectrometry","volume":"87","author":"Ouyang","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib98","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.4155\/bio.15.223","article-title":"Recent advances in 2D-LC for bioanalysis","volume":"7","author":"Stoll","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2024.116625_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463318","article-title":"Sequencing analysis of heparin reducing terminals with orthogonal chromatographic approaches","volume":"1677","author":"Zhu","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465242","article-title":"Structural elucidation of Sulodexide with multidimensional chromatography and online in-source acid-induced dissociation mass spectrometry","volume":"1733","author":"Wei","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116625_bib101","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/acs.analchem.0c03330","article-title":"Coupling liquid chromatography and tandem mass spectrometry to electrophoresis for in-depth analysis of glycosaminoglycan drugs: Heparin and the multicomponent sulodexide","volume":"93","author":"Sheng","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib102","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00216-016-0052-5","article-title":"Efficient recovery of glycosaminoglycan oligosaccharides from polyacrylamide gel electrophoresis combined with mass spectrometry analysis","volume":"409","author":"Bodet","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib103","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2105-10-87","article-title":"Decon2LS: An open-source software package for automated processing and visualization of high-resolution mass spectrometry data","volume":"10","author":"Jaitly","year":"2009","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.jpba.2024.116625_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045474","article-title":"GlycReSoft: a software package for automated recognition of glycans from LC\/MS data","volume":"7","author":"Maxwell","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2024.116625_bib105","doi-asserted-by":"crossref","first-page":"13000","DOI":"10.1021\/acs.analchem.2c01579","article-title":"Glycan mapping of low-molecular-weight heparin using mass spectral correction based on chromatography fitting with \u201cglycomapping\u201d software","volume":"94","author":"Yan","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116625_bib106","article-title":"GlycCompSoft: Software for automated comparison of low molecular weight heparins using top-down LC\/MS data","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2024.116625_bib107","doi-asserted-by":"crossref","first-page":"13987","DOI":"10.1021\/acs.analchem.2c03267","article-title":"A cluster sequencing strategy to determine the consensus affinity domains in heparin for its binding to specific proteins","volume":"94","author":"Shi","year":"2022","journal-title":"Anal. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:01:27Z","timestamp":1778752887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524006678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":107,"alternative-id":["S0731708524006678"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116625","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State-of-the-art chromatographic and mass spectrometric techniques in heparin structural analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116625"}}